Latest Allied Healthcare Products (AHPI) Headlines
Pulmonary Drug Delivery Systems Market Forecast, 2013 - 2019 Report
M2 - Fri Mar 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/cm5685/pulmonary_drug) has announced the addition of the "Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' This report studies the current scenario as well as the future market potential for pulmonary drug delivery systems, globally. The market for pulmonary drug delivery systems has been segmented into three major product types, namely, metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers. The market for these systems has been extensively analyzed on the basis of factors such as therapeutic application, geographic presence and technological developments. On the basis of therapeutic application, the market has been segmented into asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. Geographically, the market for pulmonary drug delivery systems has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. The report also provides a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global pulmonary drug delivery systems market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the global pulmonary drug delivery systems market such as AstraZeneca plc, CareFusion Corporation, GlaxoSmithKline plc, Boehringer Ingelheim, Merck & Co., 3M Health Care, Novartis AG, Omron Healthcare, Inc., PARI Respiratory Equipment, Inc., Sunovion Pharmaceuticals Inc., Philips Respironics, Inc., Allied Healthcare Products, Inc., and GF Health Products Inc. Key Topics Covered: Preface Executive Summary Market Overview Global Pulmonary Drug Delivery Systems Market Revenue, by Product Type, 2011 - 2019 (USD Million) Global Pulmonary Drug Delivery Systems Market Revenue, by Application, 2011 - 2019 (USD Million) Global Pulmonary Drug Delivery Systems Market Revenue, by Geography, 2011 - 2019 (USD Million) Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - 3M Health Care - Allied Healthcare Products, Inc. - AstraZeneca plc - Boehringer Ingelheim - CareFusion Corporation - GF Health Products, Inc. - GlaxoSmithKline plc - Merck & Co., Inc. - Novartis AG - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/cm...onary_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Allied Healthcare Products Reports Second Quarter Loss
PR Newswire - Thu Feb 13, 4:44PM CST
Continued spending curbs by hospitals and emergency agencies nationwide have resulted in depressed sales for Allied Healthcare Products, Inc. (NASDAQ: AHPI) and a loss in its second quarter of fiscal 2014.
Cambodian Transgender Activist Sou Sotheavy Wins 2014 David Kato Vision & Voice Award
PR Newswire - Tue Feb 11, 1:07PM CST
The David Kato Vision & Voice Award is proud to announce that the 2014 award will go to Cambodian transgender activist Sou Sotheavy. Now 75 years old, she has spent the last two decades working to establish a national network of organizations to support lesbian, gay, bisexual, and transgender (LGBT) people across the country. Sou will receive the award on stage at the prestigious Teddy Awards ceremony this Friday at the Berlin International Film Festival.
Pulmonary Drug Delivery Systems International Market Report 2013
M2 - Thu Nov 28, 6:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/k86tl3/global_pulmonary) has announced the addition of the "Pulmonary Drug Delivery Systems International Market Report 2013" report to their offering. The report, Pulmonary Drug Delivery Systems International Market Report 2013, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Pulmonary Drug Delivery Systems market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space 3M Healthcare Ltd., AstraZeneca plc, GlaxoSmithKline plc, and Sunovion Pharmaceuticals Inc. Key questions answered in this report: - What will the market size be in 2016 and at what will be the growth rate? - What are key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by key vendors? - What are the strengths and weaknesses of each of these key vendors? Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 6.1 Market Size and Forecast 6.2 Global MDI Market 6.3 Global DPI Market 6.4 Global Nebulizer Market 6.5 Five Forces Analysis 7. Geographical Segmentation 8. Rate of Incidence and Prevalence 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned - 3M Healthcare Ltd. - Akela Pharma Inc. - Alkermes Inc. - Allied Healthcare Products Inc. - AstraZeneca plc - Boehringer Ingelheim GmbH - CareFusion Corp. - Chiesi Farmaceutici S.p.A. - Dainippon Sumitomo Pharma Co. Ltd. - GF Health Products Inc. - GlaxoSmithKline plc - Novartis AG - Omron Healthcare Co. Ltd. - PARI Respiratory Equipment Inc. - Philips Respironics Inc. - SkyePharma plc - Sunovion Pharmaceuticals Inc. - Vectura Group plc. For more information visit http://www.researchandmarkets.com/research/k8..._pulmonary
Allied Healthcare Products Reports Loss On Depressed Sales
PR Newswire - Wed Nov 13, 3:30PM CST
Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss in the first quarter of its 2014 fiscal year on sales depressed by continuing sluggish economic conditions in the hospital market and related uncertainty about how new healthcare legislation will evolve.
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Tue Sep 17, 1:16AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Nasdaq stocks posting largest volume increases
AP - Tue Aug 27, 5:11PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Global Pulmonary Drug Delivery Systems Market 2012-2016: Intense Competition a Major Challenge Faced By the Market
M2 - Tue Jul 30, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mf9vgx/global_pulmonary) has announced the addition of the "Global Pulmonary Drug Delivery Systems Market 2012-2016" report to their offering. The analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market. Commenting on the report, an analyst from the team said: The Global Pulmonary Drug Delivery Systems market is highly fragmented with a large number of vendors having significant market shares. These vendors range from large corporations producing a broad range of advanced and premium pulmonary drug delivery systems on a worldwide scale to small and medium-sized companies that concentrate on a single product line in a specific geographic region. Further, there is strong competition from cheaper private label products also. The leading vendors are presently working on low profit because of strong competition. Moreover, there is severe pricing pressure, which leads to a reduction in vendors' profit margins. Thus, intense competition is a major challenge faced by the market, and it is expected to pose a strong challenge to the market growth during the forecast period. According to the report, one of the major drivers is the increasing prevalence of lung-related or respiratory diseases such as asthma and COPD across the globe. It is estimated that around 300 million people are suffering from asthma. This influences the market for pulmonary drug delivery inhalation devices. Companies Mentioned - 3M Healthcare Ltd. - Akela Pharma Inc. - Alkermes Inc. - Allied Healthcare Products Inc. - AstraZeneca plc - Boehringer Ingelheim GmbH - CareFusion Corp. - Chiesi Farmaceutici S.p.A. - Dainippon Sumitomo Pharma Co. Ltd. - GF Health Products Inc. - GlaxoSmithKline plc - Novartis AG - Omron Healthcare Co. Ltd. - PARI Respiratory Equipment Inc. - Philips Respironics Inc. - SkyePharma plc - Sunovion Pharmaceuticals Inc. - Vectura Group plc. For more information visit http://www.researchandmarkets.com/research/mf..._pulmonary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Breast Pumps - Global Strategic Business Report - 2013-2018
M2 - Wed Jul 10, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkqgz4/breast_pumps) has announced the addition of the "Breast Pumps - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Breast Pumps in Thousand Units by the following Product Segments: Non-Powered Breast Pumps, and Powered Breast Pumps. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 22 companies including many key and niche players such as Ameda Breastfeeding Solutions, Medela, Philips Avent, Whittlestone, Inc., Bailey Medical Engineering, Hygeia Medical Group II, Lansinoh Laboratories, Inc., Energizer Holdings, Inc., Handi-Craft Company, and TOMY Company Ltd. Key Topics Covered: Click the link below to view the full extended table of contents and e
Pulmonary Drug Delivery Systems Market Forecast, 2013 - 2019 Report
M2 - Fri Mar 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/cm5685/pulmonary_drug) has announced the addition of the "Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' This report studies the current scenario as well as the future market potential for pulmonary drug delivery systems, globally. The market for pulmonary drug delivery systems has been segmented into three major product types, namely, metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers. The market for these systems has been extensively analyzed on the basis of factors such as therapeutic application, geographic presence and technological developments. On the basis of therapeutic application, the market has been segmented into asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. Geographically, the market for pulmonary drug delivery systems has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. The report also provides a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global pulmonary drug delivery systems market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the global pulmonary drug delivery systems market such as AstraZeneca plc, CareFusion Corporation, GlaxoSmithKline plc, Boehringer Ingelheim, Merck & Co., 3M Health Care, Novartis AG, Omron Healthcare, Inc., PARI Respiratory Equipment, Inc., Sunovion Pharmaceuticals Inc., Philips Respironics, Inc., Allied Healthcare Products, Inc., and GF Health Products Inc. Key Topics Covered: Preface Executive Summary Market Overview Global Pulmonary Drug Delivery Systems Market Revenue, by Product Type, 2011 - 2019 (USD Million) Global Pulmonary Drug Delivery Systems Market Revenue, by Application, 2011 - 2019 (USD Million) Global Pulmonary Drug Delivery Systems Market Revenue, by Geography, 2011 - 2019 (USD Million) Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - 3M Health Care - Allied Healthcare Products, Inc. - AstraZeneca plc - Boehringer Ingelheim - CareFusion Corporation - GF Health Products, Inc. - GlaxoSmithKline plc - Merck & Co., Inc. - Novartis AG - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare - Sunovion Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/cm...onary_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Allied Healthcare Products Reports Second Quarter Loss
PR Newswire - Thu Feb 13, 4:44PM CST
Continued spending curbs by hospitals and emergency agencies nationwide have resulted in depressed sales for Allied Healthcare Products, Inc. (NASDAQ: AHPI) and a loss in its second quarter of fiscal 2014.
Cambodian Transgender Activist Sou Sotheavy Wins 2014 David Kato Vision & Voice Award
PR Newswire - Tue Feb 11, 1:07PM CST
The David Kato Vision & Voice Award is proud to announce that the 2014 award will go to Cambodian transgender activist Sou Sotheavy. Now 75 years old, she has spent the last two decades working to establish a national network of organizations to support lesbian, gay, bisexual, and transgender (LGBT) people across the country. Sou will receive the award on stage at the prestigious Teddy Awards ceremony this Friday at the Berlin International Film Festival.
Pulmonary Drug Delivery Systems International Market Report 2013
M2 - Thu Nov 28, 6:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/k86tl3/global_pulmonary) has announced the addition of the "Pulmonary Drug Delivery Systems International Market Report 2013" report to their offering. The report, Pulmonary Drug Delivery Systems International Market Report 2013, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Pulmonary Drug Delivery Systems market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space 3M Healthcare Ltd., AstraZeneca plc, GlaxoSmithKline plc, and Sunovion Pharmaceuticals Inc. Key questions answered in this report: - What will the market size be in 2016 and at what will be the growth rate? - What are key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by key vendors? - What are the strengths and weaknesses of each of these key vendors? Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 6.1 Market Size and Forecast 6.2 Global MDI Market 6.3 Global DPI Market 6.4 Global Nebulizer Market 6.5 Five Forces Analysis 7. Geographical Segmentation 8. Rate of Incidence and Prevalence 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned - 3M Healthcare Ltd. - Akela Pharma Inc. - Alkermes Inc. - Allied Healthcare Products Inc. - AstraZeneca plc - Boehringer Ingelheim GmbH - CareFusion Corp. - Chiesi Farmaceutici S.p.A. - Dainippon Sumitomo Pharma Co. Ltd. - GF Health Products Inc. - GlaxoSmithKline plc - Novartis AG - Omron Healthcare Co. Ltd. - PARI Respiratory Equipment Inc. - Philips Respironics Inc. - SkyePharma plc - Sunovion Pharmaceuticals Inc. - Vectura Group plc. For more information visit http://www.researchandmarkets.com/research/k8..._pulmonary
Allied Healthcare Products Reports Loss On Depressed Sales
PR Newswire - Wed Nov 13, 3:30PM CST
Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss in the first quarter of its 2014 fiscal year on sales depressed by continuing sluggish economic conditions in the hospital market and related uncertainty about how new healthcare legislation will evolve.
OTC Daily Alert Stock Watch - Allied Healthcare Products, Inc (NASDAQ: AHPI)
WorldStockWire - Tue Sep 17, 1:16AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Nasdaq stocks posting largest volume increases
AP - Tue Aug 27, 5:11PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Global Pulmonary Drug Delivery Systems Market 2012-2016: Intense Competition a Major Challenge Faced By the Market
M2 - Tue Jul 30, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mf9vgx/global_pulmonary) has announced the addition of the "Global Pulmonary Drug Delivery Systems Market 2012-2016" report to their offering. The analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market. Commenting on the report, an analyst from the team said: The Global Pulmonary Drug Delivery Systems market is highly fragmented with a large number of vendors having significant market shares. These vendors range from large corporations producing a broad range of advanced and premium pulmonary drug delivery systems on a worldwide scale to small and medium-sized companies that concentrate on a single product line in a specific geographic region. Further, there is strong competition from cheaper private label products also. The leading vendors are presently working on low profit because of strong competition. Moreover, there is severe pricing pressure, which leads to a reduction in vendors' profit margins. Thus, intense competition is a major challenge faced by the market, and it is expected to pose a strong challenge to the market growth during the forecast period. According to the report, one of the major drivers is the increasing prevalence of lung-related or respiratory diseases such as asthma and COPD across the globe. It is estimated that around 300 million people are suffering from asthma. This influences the market for pulmonary drug delivery inhalation devices. Companies Mentioned - 3M Healthcare Ltd. - Akela Pharma Inc. - Alkermes Inc. - Allied Healthcare Products Inc. - AstraZeneca plc - Boehringer Ingelheim GmbH - CareFusion Corp. - Chiesi Farmaceutici S.p.A. - Dainippon Sumitomo Pharma Co. Ltd. - GF Health Products Inc. - GlaxoSmithKline plc - Novartis AG - Omron Healthcare Co. Ltd. - PARI Respiratory Equipment Inc. - Philips Respironics Inc. - SkyePharma plc - Sunovion Pharmaceuticals Inc. - Vectura Group plc. For more information visit http://www.researchandmarkets.com/research/mf..._pulmonary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Breast Pumps - Global Strategic Business Report - 2013-2018
M2 - Wed Jul 10, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkqgz4/breast_pumps) has announced the addition of the "Breast Pumps - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Breast Pumps in Thousand Units by the following Product Segments: Non-Powered Breast Pumps, and Powered Breast Pumps. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 22 companies including many key and niche players such as Ameda Breastfeeding Solutions, Medela, Philips Avent, Whittlestone, Inc., Bailey Medical Engineering, Hygeia Medical Group II, Lansinoh Laboratories, Inc., Energizer Holdings, Inc., Handi-Craft Company, and TOMY Company Ltd. Key Topics Covered: Click the link below to view the full extended table of contents and e
